Loading...
Impact of clinicopathological features on the efficacy of immune checkpoint inhibitors plus conventional treatment in patients with advanced lung cancer
BACKGROUND: To investigate the impact of different immune checkpoint inhibitors (ICI), programmed-death ligand 1 (PD-L1) expression and clinical characteristics on clinical outcome of ICI plus conventional treatment in advanced lung cancer patients. METHODS: Randomized clinical trials that compared...
Na minha lista:
| Udgivet i: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790436/ https://ncbi.nlm.nih.gov/pubmed/31656652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.09.19 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|